# EDGAR Filing Document

**Accession Number:** 0001873093
**File Stem:** 0001641172-25-015754
**Filing Date:** 2025-6
**Character Count:** 2127
**Document Hash:** 614d4a96b4761c4a7b1e18c113a62eea
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-015754.hdr.sgml**: 20250722

**ACCESSION NUMBER**: 0001641172-25-015754

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250620

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CytoMed Therapeutics Ltd
- **CENTRAL INDEX KEY:** 0001873093
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** U0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** #08-22 ONE COMMONWEALTH
- **CITY:** 1 COMMONWEALTH LANE
- **STATE:** U0
- **ZIP:** 149544
- **BUSINESS PHONE:** 603824911

**MAIL ADDRESS:**
- **STREET 1:** #08-22 ONE COMMONWEALTH
- **CITY:** 1 COMMONWEALTH LANE
- **STATE:** U0
- **ZIP:** 149544

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CytoMed Therapeutics Pte. Ltd.
- **DATE OF NAME CHANGE:** 20210716

**CytoMed Therapeutics Limited**

1 Commonwealth Lane

#08-22

Singapore 149544

June 20, 2025

<u>VIA EDGAR</u>

Division of Corporation Finance

Office of Life Sciences

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attn: Mr. Tim Buchmiller

---

| | |
|:---|:---|
| **Re:** | **CytoMed Therapeutics Limited** |
|  | **Registration Statement on Form F-3, as amended (File No. 333- 288033)**<br> **Request for Acceleration of Effectiveness** |

---

Dear Sir,

In accordance with Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, CytoMed Therapeutics Limited hereby requests that the effectiveness of the above-referenced Registration Statement on Form F-3, as amended be accelerated to and that the Registration Statement become effective at 4:00 p.m., Eastern Time, on June 23, 2025, or as soon thereafter as practicable.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **CytoMed Therapeutics Limited** | **CytoMed Therapeutics Limited** |
| By: | */s/ Choo Chee Kong* |
| Name: | Choo Chee Kong |
| Title: | Chairman and Director |

---